Avioq News and Events
Avioq Announces FDA Approval of VioOne™ HIV Profile™ Supplemental Assay.
Avioq Announces CE Mark and European Launch of VioOne HIV Profile Supplemental Assay.
Avioq is an expanding in-vitro diagnostic medical device company
Specializing in the development, production and distribution of quality products, as well as providing flexible
contract development and manufacturing services in an FDA licensed and ISO 13485 certified environment
Apply our IVD product development experience and proven quality system to shorten your timeline.
We have experience in all phases of IVD product development, starting from raw material development and finishing with an FDA approved and/or CE marked IVD.
Avioq Announces FDA Approval of VioOne™ HIV Profile™ Supplemental Assay.
Avioq Announces CE Mark and European Launch of VioOne HIV Profile Supplemental Assay.